Authors: NESS RB GRISSO JA SCHLESSELMAN J VERGONA R KLAPPER J

Citation: Rb. Ness et al., DO LOWER DOSE ORAL-CONTRACEPTIVES PROTECT AGAINST OVARIAN-CANCER, American journal of epidemiology, 147(11), 1998, pp. 362-362

Authors: HEINEMANN LAJ LEWIS MA THOROGOOD M SPITZER WO GUGGENMOOSHOLZMANN I BRUPPACHER R BERGMAN U BRECKWOLDT M KEMPER F LELORIER J MACLEOD S MACRAE K RAY W SCHLESSELMAN J CONCIN H STARK G PFEIFFER K WEITGASSER R BEGAUD B BOISSEL B HAERTING J LAUTENSCHLAEGER F PUSCHEL K HOFFMANN F ROBRA BP LUSTERMANN M SCHULZKI I BOETHIG S GUTZWILLER F DECAESTECKER L MCCOLLUM C HANNAFORD P MANN R KUHLHABICH D KLINDWORTH C ASSMANN A

Citation: Laj. Heinemann et al., CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVES AND RISK OF THROMBOEMBOLIC STROKE - RESULTS FROM INTERNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND HEALTH OF YOUNG-WOMEN, BMJ. British medical journal, 315(7121), 1997, pp. 1502-1504

Authors: WINGO P AUSTIN H KOSINSKI A ORY H SCHLESSELMAN J ELEY W PETERSON B

Citation: P. Wingo et al., 5-YEAR SURVIVAL OF BREAST-CANCER PATIENTS BY PREVIOUS USE OF ORAL-CONTRACEPTIVES, American journal of epidemiology, 138(8), 1993, pp. 611-611